08:00 , Dec 13, 1999 |  BioCentury  |  Finance

New IPO bulge

New IPO bulge Name Location Category Actelion* Switzerland Cardiovascular Azur Environmental U.K. Agbio/Veterinary/ Environmental Biosearch Italia Italy Drug discovery Bio Tie Therapeutics Finland Blood products/ substitutes, Autoim mune/Inflammation BioVector Therapeutics* France Drug delivery Cytos Biotechnology...
08:00 , Nov 8, 1999 |  BC Week In Review  |  Company News

Centre for Applied Microbiology & Research board of directors update

Centre for Applied Microbiology & Research, Salisbury, U.K.   Business: Drug discovery   Appointed: Nigel Lightfoot, regional director of Public Health Laboratory Services North; Sandy Primrose, CEO of Azur Environmental ; Roger Whittenbury, chairman of...
08:00 , Mar 15, 1999 |  BioCentury  |  Finance

Week 1: So far so good

MorphoSys (NMarkt:MORG) didn't disappoint buyers of its $28 million IPO on the Neuer Markt, gaining 43 percent in trading after last Tuesday's offering to close Friday at Eur35.7, a market cap of Eur122.4 million ($132.6...
08:00 , Nov 3, 1997 |  BC Week In Review  |  Company News

Tepnel board of directors update

Tepnel Life Sciences PLC (LSE:TED), Knutsford, U.K.   Business: Diagnostics/Imaging   Resigned: Anthony Martin, chairman and CEO of Azur Environmental , as a non-executive director and deputy chairman  ...